Metacrine, Inc.
MTCR · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $21 | $21 | $26 | $28 |
| - Cash | $53 | $45 | $33 | $49 |
| + Debt | $14 | $14 | $13 | $14 |
| Enterprise Value | -$18 | -$11 | $6 | -$6 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$6 | -$12 | -$14 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$7 | -$13 | -$14 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.13 | -0.16 | -0.31 | -0.33 |
| % Growth | 18.8% | 48.4% | 6.1% | – |
| Operating Cash Flow | -$3 | -$8 | -$14 | -$12 |
| Capital Expenditures | $0 | $0 | $0 | -$0 |
| Free Cash Flow | -$3 | -$8 | -$14 | -$12 |